Avista Healthcare Partners acquires Bag Balm

Avista Healthcare Partners has acquired Bag Balm, a Vermont-based therapeutic skincare brand, as part of its establishment of Birchwell Consumer Health, a new U.S. consumer healthcare platform. The financial terms of the transaction were not disclosed. This acquisition marks the inaugural investment for Birchwell, a platform created to consolidate over-the-counter and skincare brands that deliver distinctive healthcare solutions.

Bag Balm, founded in 1899 and best known for its multi-use ointment, is distributed nationally through both physical and online retail channels. The acquisition from a seller group led by Gemini Investors aligns with Avista's strategic plan to leverage established, trusted brands in the consumer healthcare sector. Birchwell represents Avista's eighth global consumer healthcare platform and its fourth in North America, highlighting the firm's focus on healthcare investments.

Avista's creation of Birchwell and acquisition of Bag Balm indicates a strategic move to capture growth in the consumer healthcare market, especially as the demand for accessible and affordable self-care products rises. Alex Yu, Partner at Avista, underscored the firm's commitment to consumer healthcare, citing secular trends favoring self-care and over-the-counter product solutions. The goal is to revive and enhance the growth of reputable brands like Bag Balm that have shown consistent market appeal.

The acquisition positions Avista to potentially influence the competitive dynamics within the therapeutic skincare sector. As consumers increasingly gravitate towards trusted brands for wellness solutions, rivals may feel pressure to either innovate or pursue similar consolidation strategies. With Birchwell as a new vehicle for expansion, Avista aims to capitalize on consumer trends that favor legacy products with demonstrated efficacy and strong brand loyalty.

Moving forward, the focus will be on integrating Bag Balm into Birchwell’s operations and leveraging Avista's resources to scale the brand further. While financial specifics remain under wraps, the deal’s impact on Avista's broader strategy within the consumer healthcare landscape will be closely monitored. Adjustments to Bag Balm’s product offerings or distribution networks could be considered as part of the growth agenda.